Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
17.12
-0.40 (-2.28%)
Dec 31, 2025, 4:00 PM EST - Market closed
Evommune Market Cap
Evommune has a market cap or net worth of $539.69 million as of December 31, 2025.
Market Cap
539.69M
Enterprise Value
464.40M
1-Year Change
n/a
Ranking
Category
Stock Price
17.12
Market Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has increased from $481.24M to $539.69M, an increase of 12.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 552.30M | -2.67% |
| Dec 29, 2025 | 567.43M | 4.59% |
| Dec 26, 2025 | 542.53M | -2.16% |
| Dec 24, 2025 | 554.51M | -1.79% |
| Dec 23, 2025 | 564.60M | 4.68% |
| Dec 22, 2025 | 539.38M | -6.25% |
| Dec 19, 2025 | 575.31M | 21.59% |
| Dec 18, 2025 | 473.18M | -5.72% |
| Dec 17, 2025 | 501.86M | 0.38% |
| Dec 16, 2025 | 499.97M | -10.04% |
| Dec 15, 2025 | 555.77M | -2.11% |
| Dec 12, 2025 | 567.75M | -8.53% |
| Dec 11, 2025 | 620.71M | 5.24% |
| Dec 10, 2025 | 589.82M | 9.92% |
| Dec 9, 2025 | 536.58M | -3.25% |
| Dec 8, 2025 | 554.63M | -15.80% |
| Dec 5, 2025 | 658.70M | -0.14% |
| Dec 4, 2025 | 659.60M | 3.35% |
| Dec 3, 2025 | 638.25M | 0.81% |
| Dec 2, 2025 | 633.13M | 0.67% |
| Dec 1, 2025 | 628.92M | 0.97% |
| Nov 28, 2025 | 622.91M | 6.70% |
| Nov 26, 2025 | 583.81M | 3.52% |
| Nov 25, 2025 | 563.95M | -3.25% |
| Nov 24, 2025 | 582.90M | 3.58% |
| Nov 21, 2025 | 562.75M | - |
| Nov 20, 2025 | 562.75M | -3.01% |
| Nov 19, 2025 | 580.20M | -4.46% |
| Nov 18, 2025 | 607.27M | 3.80% |
| Nov 17, 2025 | 585.01M | 6.28% |
| Nov 14, 2025 | 550.42M | 0.44% |
| Nov 13, 2025 | 548.01M | -6.66% |
| Nov 12, 2025 | 587.11M | 0.26% |
| Nov 11, 2025 | 585.61M | 0.78% |
| Nov 10, 2025 | 581.10M | 4.94% |
| Nov 7, 2025 | 553.73M | 15.06% |
| Nov 6, 2025 | 481.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |